SHINE Technologies is a fusion-based isotope company that produces non-carrier-added Lu-177 (Ilumira) and is building the Chrysalis Mo-99 plant.
SHINE Technologies, based in Janesville, Wisconsin, is a fusion-based isotope company that produces non-carrier-added lutetium-177, sold as Ilumira, and is building the Chrysalis molybdenum-99 plant. It has supplied lutetium-177 to radiopharmaceutical developers since 2022, its large-scale Mo-99 facility is under construction, and it holds long-term fusion energy ambitions. OnCo links it to the therapeutic isotope supply chain for Mo-99, Lu-177 and Ac-225. Whether a second Western source of lutetium-177 makes supply resilient enough for radioligand therapy to scale is the open question. The isotope supply chain page carries the wider picture.
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Research reactors for medical isotopes (Mo-99, Lu-177, I-131) and the tag supporting.
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Research reactors for medical isotopes (Mo-99, Lu-177, I-131).
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Research reactors for medical isotopes (Mo-99, Lu-177, I-131).
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Research reactors for medical isotopes (Mo-99, Lu-177, I-131) and the tag supporting.
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Research reactors for medical isotopes (Mo-99, Lu-177, I-131).
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Research reactors for medical isotopes (Mo-99, Lu-177, I-131).
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Research reactors for medical isotopes (Mo-99, Lu-177, I-131) and the tag supporting.
Shares Research reactors for medical isotopes (Mo-99, Lu-177, I-131) and the tag supporting.